[HTML][HTML] GLP-1 receptor agonists in the treatment of type 2 diabetes–state-of-the-art
MA Nauck, DR Quast, J Wefers, JJ Meier - Molecular metabolism, 2021 - Elsevier
Background GLP-1 receptor agonists (GLP-1 RAs) with exenatide bid first approved to treat
type 2 diabetes in 2005 have been further developed to yield effective compounds/…
type 2 diabetes in 2005 have been further developed to yield effective compounds/…
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
JJ Meier - Nature Reviews Endocrinology, 2012 - nature.com
In healthy humans, the incretin glucagon-like peptide 1 (GLP-1) is secreted after eating and
lowers glucose concentrations by augmenting insulin secretion and suppressing glucagon …
lowers glucose concentrations by augmenting insulin secretion and suppressing glucagon …
[HTML][HTML] Glucagon-like peptide 1 (GLP-1)
…, JF Habener, JJ Holst, W Langhans, JJ Meier… - Molecular …, 2019 - Elsevier
Background The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad
pharmacological potential. Among the numerous metabolic effects of GLP-1 are the glucose-…
pharmacological potential. Among the numerous metabolic effects of GLP-1 are the glucose-…
Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences
In the field of artificial intelligence, a combination of scale in data and model capacity
enabled by unsupervised learning has led to major advances in representation learning and …
enabled by unsupervised learning has led to major advances in representation learning and …
The historical Jesus: The life of a Mediterranean Jewish peasant
JD Crossan, JP Meier - 1991 - philpapers.org
… Meier, The Historical Jesus: The Life of a Mediterranean Jewish Peasant - PhilPapers …
Meier … ‘ Noli Me Tangere’: Why John Meier Won't Touch the Risen Lord.…
Meier … ‘ Noli Me Tangere’: Why John Meier Won't Touch the Risen Lord.…
Thin‐film silicon solar cell technology
AV Shah, H Schade, M Vanecek, J Meier… - Progress in …, 2004 - Wiley Online Library
This paper describes the use, within p–i–n‐ and n–i–p‐type solar cells, of hydrogenated
amorphous silicon (a‐Si:H) and hydrogenated microcrystalline silicon (μc‐Si:H) thin films (layers…
amorphous silicon (a‐Si:H) and hydrogenated microcrystalline silicon (μc‐Si:H) thin films (layers…
Improved search for muon-neutrino to electron-neutrino oscillations in MINOS
…, N Mayer, AM McGowan, R Mehdiyev, JR Meier… - Physical Review Letters, 2011 - APS
We report the results of a search for ν e appearance in a ν μ beam in the MINOS long-baseline
neutrino experiment. With an improved analysis and an increased exposure of 8.2× 10 20 …
neutrino experiment. With an improved analysis and an increased exposure of 8.2× 10 20 …
Complete microcrystalline p‐i‐n solar cell—Crystalline or amorphous cell behavior?
J Meier, R Flückiger, H Keppner, A Shah - Applied Physics Letters, 1994 - pubs.aip.org
Complete μc‐Si:H p‐i‐n solar cells have been prepared by the very high frequency glow
discharge method. Up to now, intrinsic μc‐Si:H has never attracted much attention as a …
discharge method. Up to now, intrinsic μc‐Si:H has never attracted much attention as a …
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology
The aims of severe perioperative bleeding management are three-fold. First, preoperative
identification by anamesis and laboratory testing of those patients for whom the perioperative …
identification by anamesis and laboratory testing of those patients for whom the perioperative …
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016
The management of perioperative bleeding involves multiple assessments and strategies to
ensure appropriate patient care. Initially, it is important to identify those patients with an …
ensure appropriate patient care. Initially, it is important to identify those patients with an …